Effect of Exenatide, Metformin and Folic Acid on Experimentally Induced Metabolic–Cognitive Syndrome in Rats. | ||
Benha Medical Journal | ||
Volume 37, Issue 1, May 2020 PDF (1.1 M) | ||
Document Type: Original Article | ||
DOI: 10.21608/bmfj.2020.22710.1206 | ||
Authors | ||
Ahmed Fathy Bahriz1; Mohamed El-Metwally Mansour2; Amany Nasr Ibrahim3; Doaa Mohamady Khalil* 4; Heba Abd El-Hafeez El-Noury5 | ||
1professor of clinical pharmacology, faculty of medicine, banha univerisity | ||
2professor of clinical pharmacology, faculty of medicine,benha univerisity | ||
3Assistant Professor of Clinical Pharmacology, Faculty of Medicine Benha University | ||
4Assistant lecturer, clinical pharmacology department, faculty of medicine, banha univerisity | ||
5Lecturer of clincal pharmacology,faculty of medicine ,benha university | ||
Abstract | ||
ABSTRACT Background: Metabolic syndrome (MetS) and its relationship with cognitive impairment has been the subject of extensive research. Purpose: This study was designed to determine the effect of MetS on cognitive function, and the possibility of modulating this effect by exenatide, metformin and folic acid. Materials and Methods: 30 adult male albino rats were divided in 5 groups. Group (I): received a standard rat chow, Group (II): MetS none treated rats fed with 60% fructose added to the standard rat chow, Group (III): MetS treated with exenatide, Group (IV): MetS treated with metformin, Group (V): MetS treated with folic acid. At the end of the experiment, fasting blood glucose, fasting plasma insulin, HOMA-IR index, serum triglyceride, HDL-C, dopamine and BDNF levels in brain tissue were measured and cognitive performance was assessed by Morris water maze (MWM) test. Results: MetS rats increased fasting blood glucose, fasting plasma insulin, HOMA-IR index, arterial blood pressure, serum triglycerides and decreased HDL-C, dopamine and BDNF and showed memory impairment in MWM test. All treated groups resulted in decrease in fasting blood glucose, fasting plasma insulin, HOMA-IR index, arterial blood pressure, and serum triglycerides and increase in HDL-C, dopamine and BDNF. Also showed memory improvement in MWM test. Conclusion: MetS was associated with cognitive impairment. Exenatide, metformin and folic acid improved cognitive function in addition to improvement of metabolic parameters. | ||
Keywords | ||
cognition; exenatide; folic acid; metabolic syndrome; metformin | ||
Statistics Article View: 64 PDF Download: 26 |